Showing results (361-370 of 415) with videos related to

Sort By:
Pageof 42
International Journal of Radiation Oncology, Biology, Physics|June 15, 2014
Addressing the growing cancer burden in the wake of the AIDS epidemic in Botswana: The BOTSOGO collaborative partnershipJason A Efstathiou, Memory Bvochora-Nsingo, David P Gierga, et al.
Blood Advances|January 1, 2024
Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLLInhye E Ahn, Danielle M Brander, Yue Ren, et al.
Cancer Cytopathology|December 27, 2022
Small volume biopsy diagnostic yield at initial diagnosis versus recurrence/transformation of follicular lymphoma: A retrospective Cyto-Heme Interinstitutional Collaborative studyMegan J Fitzpatrick, Vandana Sundaram, Amy Ly, et al.
Transplantation and Cellular Therapy|June 13, 2025
Clinical practice recommendations on the role of allogeneic hematopoietic cell transplantation and chimeric antigen receptor T-cell therapy in patients with chronic lymphocytic leukemia on behalf of the American Society for Transplantation and Cellular TherapyMohamed A Kharfan-Dabaja, Ambuj Kumar, Javier Pinilla-Ibarz, et al.
The Lancet. Haematology|December 4, 2018
Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 studyKieron Dunleavy, Michelle A Fanale, Jeremy S Abramson, et al.
Blood|July 16, 2026
Durable efficacy and manageable long-term safety of lisocabtagene maraleucel in 3L+ FL: 3-year update from TRANSCEND FLSairah Ahmed, Alejandro Martin Garcia-Sancho, Juan Luis Reguera-Ortega, et al.
Blood Advances|January 4, 2018
Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HLMonika Pilichowska, Stefania Pittaluga, Judith A Ferry, et al.
Leukemia & Lymphoma|June 28, 2021
Impact of initial biopsy type on the time to final diagnostic biopsy in patients with follicular lymphoma and suspected histologic transformationEric Mou, Lorenzo Falchi, Vandana Sundaram, et al.
Blood|September 22, 2023
Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective studyDavid A Qualls, Nicholas Lambert, Paolo F Caimi, et al.
Blood|October 22, 2024
Zanubrutinib, obinutuzumab, and venetoclax for first-line treatment of mantle cell lymphoma with a TP53 mutationAnita Kumar, Jacob Soumerai, Jeremy S Abramson, et al.
Pageof 42